v3.26.1
Segment Reporting
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 10 – SEGMENT REPORTING

 

A. Information about reported segment profit or loss and assets

 

The Company operates as a single operating segment. The Company’s chief operating decision-maker (“CODM”) is its chief executive officer, who reviews financial information presented on a consolidated basis. The CODM uses consolidated Net loss and Operating loss to monitor budget versus actual results in assessing segment performance and the allocation of resources. Significant segment expenses are presented in the Company’s consolidated statements of operations.

 

Additional disaggregated significant segment expenses on a functional basis, that are not separately presented on the Company’s consolidated statements of operations, regularly reviewed by the Company’s CODM, include salaries and clinical trials expenses and presented below.

 

    Three months ended     Six months ended  
    June 30     June 30  
    2026     2025     2026     2025  
                         
Revenues from defense business     332       -       332       -  
Cost of revenues     235       -       235       -  
Gross profit     97       -       97       -  
                                 
Operating expenses:                                
Salaries and related expenses, other than share-based compensation     429       1,932       2,202       3,909  
Clinical trials     -       3,424       95       7,049  
Stock based compensation     3,988       696       2,060       1,355  
Depreciation expenses     4       292       4       528  
Insurance     623       -       1,466       -  
Other segment items (*)     370       1,089       883       2,348  
Total Operating loss     5,414       7,433       6,710       15,189  

 

(*) Other segment items include all remaining costs necessary to operate the Company’s business, which primarily include external professional services, rent and other administrative expenses, and are presented net of grants received

 

The Company’s Property and equipment, as well as the Company’s operating lease right-of-use assets recognized on the consolidated balance sheets were located as follows:

 

    As of
June 30,
2026		     As of December 31,
2025		  
             
Israel     99       157  
United States     2       -  
Total     101       157